ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/381968408a467e86507531b7cb02d169.pdf

Abstract Title

First Name *

Robert

Last Name *

Schmouder

Co-author 1

Kenneth Kulmatycki kenneth.kulmatycki@novartis.com Novartis Institutes of BioMedical Research Pharmacokinetic Science Cambridge

Co-author 2

Elise Burmeister Getz elise.burmeister-getz@novartis.com Novartis Institutes of BioMedical Research Pharmacokinetic Science Emeryville

Co-author 3

Wendy Weiss wendy.weis@novartis.com Novartis Pharmaceuticals Corporation Clinical Trial Lead East Hanover

Co-author 4

Bharti Shah bharti.shah@novartis.com Novartis Pharmaceuticals Corporation Pharmacokinetic Science East Hanover

Co-author 5

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15